Domain swapping in allosteric modulation of DNA specificity

SgrAI is a type IIF restriction endonuclease that cuts an unusually long recognition sequence and exhibits allosteric self-modulation of cleavage activity and sequence specificity. Previous studies have shown that DNA bound dimers of SgrAI oligomerize into an activated form with higher DNA cleavage...

Full description

Saved in:
Bibliographic Details
Published inPLoS biology Vol. 8; no. 12; p. e1000554
Main Authors Park, Chad K, Joshi, Hemant K, Agrawal, Alka, Ghare, M Imran, Little, Elizabeth J, Dunten, Pete W, Bitinaite, Jurate, Horton, Nancy C
Format Journal Article
LanguageEnglish
Published United States Public Library of Science 01.12.2010
Public Library of Science (PLoS)
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:SgrAI is a type IIF restriction endonuclease that cuts an unusually long recognition sequence and exhibits allosteric self-modulation of cleavage activity and sequence specificity. Previous studies have shown that DNA bound dimers of SgrAI oligomerize into an activated form with higher DNA cleavage rates, although previously determined crystal structures of SgrAI bound to DNA show only the DNA bound dimer. A new crystal structure of the type II restriction endonuclease SgrAI bound to DNA and Ca(2+) is now presented, which shows the close association of two DNA bound SgrAI dimers. This tetrameric form is unlike those of the homologous enzymes Cfr10I and NgoMIV and is formed by the swapping of the amino-terminal 24 amino acid residues. Two mutations predicted to destabilize the swapped form of SgrAI, P27W and P27G, have been made and shown to eliminate both the oligomerization of the DNA bound SgrAI dimers as well as the allosteric stimulation of DNA cleavage by SgrAI. A mechanism involving domain swapping is proposed to explain the unusual allosteric properties of SgrAI via association of the domain swapped tetramer of SgrAI bound to DNA into higher order oligomers.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
a: Current address: Boehringer Ingelheim, St. Joseph, Missouri, United States of America
The author(s) have made the following declarations about their contributions: Conceived and designed the experiments: CKP AA JB NH. Performed the experiments: CKP HKJ AA MIG NH. Analyzed the data: CKP MIG PWD NH. Contributed reagents/materials/analysis tools: CKP AA EJL JB NH. Wrote the paper: CKP JB NH.
b: Current address: Ventana Medical Systems, Tucson, Arizona, United States of America
ISSN:1545-7885
1544-9173
1545-7885
DOI:10.1371/journal.pbio.1000554